Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
730 Ryanodine Inhibits the Release of Calcium from Intracellular Stores in Guinea Pig Aortic Smooth Muscle Katsuaki Ito, Sachiko Takakura, Kohichi Sato, and John L. Sutko From the Department of Veterinary Pharmacology, Faculty of Agriculture, University of Miyazaki, Miyazaki, Japan, and the Departments of Physiology and Internal Medicine (Cardiology Division), The University of Texas Health Science Center, Dallas, Texas Downloaded from http://circres.ahajournals.org/ by guest on June 18, 2017 SUMMARY. We have examined the effects of ryanodine, an inhibitor of the release of sarcoplasmic reticulum calcium in cardiac muscle, on contractile tension and calcium-45 movement in aortic smooth muscle of guinea pigs to learn whether this agent also modifies the release of stored calcium in vascular smooth muscle. Ryanodine (3-100 /*M) suppressed the phasic contractions induced by caffeine and norepinephrine in calcium-free medium and prevented the stimulation of calcium-45 efflux by these agonists. Ryanodine did not significantly alter either the contractile response or the increased cellular influx of calcium-45 caused by high potassium in more than 1 mM calcium, suggesting that this agent does not affect depolarization-induced calcium entry into the cells. In a calcium-free, high potassium solution, the addition of calcium at concentrations of 1 mvi and less resulted in a contraction which appeared to depend largely on the release of calcium from intracellular stores. This contraction was blocked by ryanodine. These data are consistent with the hypothesis that ryanodine causes a diminished release of calcium from the intracellular store in vascular smooth muscle, as it does in cardiac muscle. Moreover, our results indicate that a calcium-induced calcium release may exist in smooth muscle, and that this release is antagonized by ryanodine. (Circ Res 58: 730-734, 1986) IT HAS been suggested that mobilization of calcium from intracellular stores, presumably sarcoplasmic reticulum (SR), in vascular smooth muscles, underlies the contractile effects of agents such as vasoactive amines and peptides 0ohansson and Somlyo, 1980). Nevertheless, the role of the SR in regulating intracellular calcium concentration in vascular smooth muscle is not well understood, due to its low density and distribution in the cell, and to difficulties in isolating SR membranes from vascular smooth muscles. Pharmacological interventions which modify the release of intracellularly stored calcium have been used to investigate the contributions made by intracellularly stored calcium to smooth muscle contractions. These interventions include caffeine and local anesthetics, such as procaine (Endo, 1977; Itoh et al., 1981; Saida, 1982). However, a limitation to the use of these agents is that both caffeine and procaine decrease the influx of calcium from the extracellular space (Jacobs and Keatinge, 1974; Leijten and Van Breemen, 1984; Spedding and Berg, 1985). Therefore, it is difficult to differentiate the effect of these agents on the calcium release from that on the calcium influx when intact smooth muscle is used. Ryanodine, a naturally occurring alkaloid, has been demonstrated to alter specifically calcium movements across SR membranes in cardiac and skeletal muscles (Jenden and Fairhurst, 1969; Sutko et al., 1979; Sutko and Willerson, 1980; Fabiato, 1985; Sutko et al., 1985). Moreover, this agent alters the mechanical responses of certain smooth muscle preparations in a manner that suggests that it might produce similar effects in this tissue (Steinsland et al., 1973). If ryanodine selectively modifies the function of the SR, it will be a powerfull tool for the study of the role of the SR in vascular smooth muscle contraction. The present study was undertaken to learn how ryanodine modifies the release of calcium from intracellular stores in guinea pig aortic smooth muscle. The results suggest that this agent blocks the release of intracellularly stored calcium caused by norepinephrine (NE) and caffeine, but does not affect depolarization-dependent calcium entry from the extracellular space. Methods Aortas were isolated from 250- to 400-g male guinea pigs following a blow on the neck. For tension experiments, the helical strip of aorta was suspended in an organ bath filled with 10 ml Tyrode's solution containing (mM): NaCl, 136.8; KC1, 5.4; MgCl2, 0.5; NaHCO3, 11.9; and dextrose, 5.5; gassed with 95% O2 and 5% CO2 (pH 7.4; 37°C). High potassium solution was prepared either by hypertonically increasing KG to 60 mM or by isotonically substituting KC1 for NaCl. Norepinephrine (Sigma) and ryanodine (lot 704 RWP-1, S.P. Penick Corp.) were added to the Tyrode's solution from 1 mM stock solution, while caffeine (Nakarai Chemicals) was dissolved directly in the lto et al./Effect of Ryanodine on Vascular Smooth Muscle Downloaded from http://circres.ahajournals.org/ by guest on June 18, 2017 buffer solution. The muscle strip was placed under 1 g of resting tension, and its isometric tension was recorded. The muscle was equilibrated for 30 minutes and then was treated alternately with 60 mM KC1 and 1 fiM NE until stable reproducible contractions were obtained. For 45Ca flux experiments, the solutions were buffered with tris(hydroxymethyl)aminomethane (Tris) and gassed with 100% O2 to avoid precipitation in the medium due to the presence of lanthanum. We had ensured, in preliminary experiments, that the results of tension experiments in Tris buffer were identical with those in a bicarbonate buffer. Uptake of 45Ca by aortic muscles was measured by a cold lanthanum wash procedure (Karaki and Weiss, 1979). First, the muscles were depleted of calcium by 20 minutes of exposure to 10 /*M NE in calcium-free medium, and then were transferred to calcium-free, potassiumdepolarizing solution containing KG, 142; MgCU, 0.5; dextrose, 5.5; 5 mM Tris (pH 7.4). Fifteen minutes later, 1 mM calcium containing 45Ca (1 /iCi/ml) was added. After incubation with 45Ca for 5 or 30 minutes, the muscles were transferred to lanthunum solution (LaCl3, 80.8; dextrose, 11; and Tris, 5 mM; pH 6.8) cooled to 0.5°C. The residual 45Ca content after 60 minutes of incubation in cold lanthanum solution was determined as the net cellular 45Ca uptake. For the measurement of 45Ca efflux, the muscles were loaded with 45Ca during a 150-minute incubation period in Tyrode's solution containing 45Ca (2 jiCi/ml; total calcium was 2.5 mM). The muscles then were placed in a calcium-free medium, and the efflux of 45Ca was initiated. The efflux medium was changed every 10 minutes. After 60-80 minutes, the muscles were exposed to 10 HM NE or 20 mM caffeine. The radioactivity in the efflux medium was counted in a liquid scintillation counter. Data are expressed as rate coefficient, which means the percent loss of 45Ca content during each washing interval. Data represent the mean ± SEM. Differences were considered to be significant at the level of P < 0.05 when tested by Student's /-test. Results When 2.5 HIM calcium was present in the external medium, pretreatment of aortic muscles with 30 or 100 HM ryanodine did not significantly affect the rate of tension development and the peak amplitude of the contraction elicited by 60 mM potassium (n = 8 for each concentration). On the other hand, 30 JUM ryanodine slowed the development of responses to 1 fiM NE (the time for half-maximal response increased from 19 ± 3 seconds to 96 ± 17 seconds; P < 0.05) and decreased its peak tension by 22 ± 8% ( P < 0 . 0 5 ; H = 8). In calcium-free solutions containing 0.5 mM EGTA, both caffeine (5-10 mM) and NE (1 I*M) induced an initial phasic contraction which, in the case of NE, was followed by a tonic one. Ryanodine selectively suppressed the phasic contraction due to both agents in a dose-dependent manner (Fig. 1). The ryanodine-insensitive tonic contraction produced by NE was decreased by elevating the concentration of EGTA in the medium to 2 mM, supporting the view that this component was due to entry of superficially bound calcium or to the release 731 Caffeine Ryanodine Caffeine 7 T ? ]0.2g CCa-1, 2.5mM 0 mM 1 2.5mM 3 10 OmM 30 Ryanodine (uM) FIGURE 1. Suppression of the phasic contractions induced by caffeine and norepinephrine (NE) in calcium-free medium by ryanodine. After a 15-minute incubation in calcium-free medium containing 0.5 mM EGTA, aortic strips were contracted with either 10 niM caffeine or 1 HM NE. After the agonists from the organ bath were washed, the muscles were equilibrated in 2.5 niM calcium for 30 minutes. The external medium was then changed to the calcium-free medium containing ryanodine. Panel A: abolition by 30 HM ryanodine of caffeine-induced contraction. Panel B: suppression by 10 HM ryanodine of NE-induced phasic contraction. Panel C: concentration-dependence of the effects of ryanodine on the phasic (closed circle) and tonic (open circle) contractions induced by 1 HM NE in calcium-free medium containing 0.5 mM EGTA. The ordinate represents the relative amplitude of the contraction as compared to the maximum contraction induced by 60 mM KCI in 2.5 niM calcium-Tyrode's solution. Each point represents a mean of seven preparations with SEM. of calcium from intracellular site which can be readily depleted by extracellular EGTA (Wheeler and Weiss, 1979; Karaki and Weiss, 1980a, 1980b). NE (10 IIM) and caffeine (20 mM) increased the 45 Ca efflux from aortic muscles into calcium-free medium, which effect is thought to result from an acceleration of release of stored calcium by these agents (Godfraind, 1976; Deth and Casteels, 1977; Casteels and Droogmans, 1981). As shown in Figure 2, the presence of 30 fiM ryanodine prevented this effect caused by NE. Similarly, ryanodine prevented the increase of 45Ca efflux caused by 20 mM caffeine (data not shown). Thus, the results shown in Figures 732 ^ Circulation Research/Vol. 58, No. 5, May 1986 5 E "; 4 I 3 O 0 L 60 30 120 90 Time (min) Downloaded from http://circres.ahajournals.org/ by guest on June 18, 2017 FIGURE 2. Inhibition by ryanodine of the stimulation by 10 IXM NE of the i5Ca efflux from the aortic muscles. After the muscles were loaded with 4SCa for 150 minutes, the muscles ivere exposed to the efflux medium which was changed every 10 minutes. After 60-80 minutes muscles were exposed to 10 \IM NE. When present, 30 fiM ryanodine was added 20 minutes prior to NE, as indicated by arroiv (filled circle). Open circle: control. Each curve represents the average of four preparations. 1 and 2 clearly indicate that ryanodine inhibits the release of calcium from the intracellular stores sensitive to NE or caffeine. In the next series of experiments, we examined N.S. 200 T T 150 o c N.S. 100 Q. o o 50 0 L (mM) 5.4 142 142 + Ry 5 min 5.A K2 • Ry 30 min FIGURE 3. Cellular uptake of45Ca into aortic muscles in the presence of 5.4 HIM or 142 mM potassium. After the intracellular calcium store was depleted by 10 HMNE in calcium-free medium, the muscles were exposed to calcium-free medium containing 5.4 HIM or 142 mM potassium. Twenty minutes later, 1 HIM calcium with >5Ca was added. The muscles were allowed to take up <5Ca for 5 or 30 minutes, and were then transferred to the lanthanum solution at 0.5°C to measure cellular *5Ca uptake. In the ryanodine-treated group (Ry), 30 HM ryanodine was present in the calcium-free, 142 mM potassium solution. Each bar represents a mean of eight preparations with SEM. N.S. = not significant. the effects of ryanodine on the contraction of aortic smooth muscle resulting from the reintroduction of calcium to muscles previously incubated in calciumfree, high potassium (140 mM) solution. Ryanodine (30 HM) significantly decreased the calcium-induced contraction of the muscles by 73 ± 6%, 57 ± 6%, and 42 ± 4% (n = 7) when the concentration of calcium added was 0.1, 0.3, and 1.0 mM, respectively. However, ryanodine did not significantly inhibit the contraction when the added calcium exceeded 2 mM. The suppression of this contraction could be due to inhibition by ryanodine of either calcium influx into the cell or of calcium-induced calcium release from the intracellular stores. To test these possibilities, we first examined the effect of ryanodine on the uptake of calcium by the muscles (Fig. 3). After the muscles had been incubated in calcium-free, isotonic potassium solution for 20 minutes, 1 mM calcium with 45Ca was added. High potassium significantly increased 45Ca uptake into the muscle cells. Ryanodine (30 /J.M) did not significantly affect the 45Ca uptake increased by high potassium. The results suggest that ryanodine does not affect depolarization-dependent calcium entry from the external medium. This hypothesis is consistent with the fact that ryanodine did not affect the contraction induced by 60 mM potassium in the presence of 2.5 mM calcium. To assess the second possibility, we examined the dependency of the calcium-induced contraction on the extent of calcium loading of the intracellular store (Fig. 4). In one group of muscles, the intracellular store was filled with calcium by exposing the muscles to a medium containing 60 mM KG and 2.5 mM calcium just before the introduction of calciumfree, high potassium solution. The ability of this procedure to load intracellular calcium stores was confirmed in separate experiments in which NEinduced phasic contractions obtained in calciumfree medium were shown to be augmented by this procedure. In a second group, the intracellular calcium store was depleted of calcium by three successive exposures to 1 HM NE in calcium-free buffer. Contractions that developed during the initial 5 minutes after the addition of 0.1 mM calcium were compared, since the calcium store might be significantly replenished after longer times. Figure 4 shows that both the rate of development and the amplitude of the contractions induced by 0.1 mM calcium were greater in the calcium-loaded than in the calciumdepleted muscles. Ryanodine suppressed the calcium-induced contraction developed for 5 minutes after exposure to calcium in the calcium-loaded muscles, but not in those that had been depleted of calcium. These results suggest that intracellularly stored calcium makes a significant contribution to the calcium-induced contraction elicited from depolarized muscles with intact calcium stores, and that a calcium-induced calcium release mechanism may be operable in this preparation. lto et fl/./Effect of Ryanodine on Vascular Smooth Muscle 30 CQ - depleted g 20 o O c o o 10 0 100 r Downloaded from http://circres.ahajournals.org/ by guest on June 18, 2017 2 3 Time (min) FIGURE 4. Effects of ryanodine on calcium-induced contractions in potassium-depolarized aortic smooth muscles. Upper panel: calciumdepleted muscles. The muscles were depleted of calcium by three successive applications of NE in the calcium-free medium containing 0.5 HIM ECTA. Subsequently, the external medium was changed to the calcium-free, potassium-depolarizing medium (142 niM KC1, no ECTA). Lower panel: calcium-loaded muscles. Aortic muscles were loaded with calcium by application of 60 IUM potassium and 2.5 niM calcium just before changing to a calcium-free, high-potassium solution. In both panels, when present (open circle), 30 /JM ryanodine was added when the external medium ivas changed to the calciumfree, high potassium solution. Closed circle: control. Data represent mean of seven preparations with SEM. 'Significantly different from control (P < 0.05). Discussion The results obtained in this study suggest that ryanodine can diminish the release of calcium from intracellular stores in vascular smooth muscle without affecting the calcium influx from the extracellular space. The selective inhibition by ryanodine of only those contractions which involve the release of calcium from intracellular sites means that this agent has an advantage over caffeine or local anesthetics as a tool for the study of smooth muscle contraction. This selectivity also argues against an effect on subsequent steps in the smooth muscle contractile mechanism, such as myosin light chain kinase, which could be common to all of the agents tested. Although experimental verification is required, we are presently assuming from analogies with striated muscles that the SR is the intracellular calcium store affected by agents such as ryanodine and caffeine. This conclusion has been reached by other authors 733 (Casteels and Droogmans, 1981; Itoh et al., 1982; Bond et al., 1984a, 1984b). Relatively high concentrations of ryanodine are required to affect vascular smooth muscle. This apparent insensitivity may be explained by the use- or depolarization-dependence exhibited by the actions of this agent on both skeletal and cardiac muscles (Sutko et al., 1985), as well as by the actual characteristics of the ryanodine-binding site. Calcium-induced contraction of depolarized muscles seemed to depend on calcium loading of the cells. However, we must consider an alternative possibility that this contraction might depend on superficially bound calcium. Since NE treatment, used to deplete calcium, can remove superficially bound calcium (Wheeler and Weiss, 1979; Karaki and Weiss, 1980a, 1980b), the different amounts of superficially bound calcium in two groups may explain the difference between the responses to 0.1 mM calcium if calcium at this site contributes to the calcium-induced contraction. As for this fraction of calcium, ryanodine does not seem to affect the mobilization of superficially bound calcium, since this agent did not inhibit the tonic contraction induced by NE in calcium-free medium. On the contrary, ryanodine greatly inhibited the contraction induced by calcium in calcium-loaded muscles. Therefore, we can conclude that calcium-induced contraction of depolarized muscle did not depend on superficially bound calcium, but on intracellularly stored calcium. It has been suggested that calcium-induced calcium release underlies the caffeine-induced contraction in certain vascular smooth muscles (Itoh et al., 1981,1982; Saida and Van Breemen, 1984). Caffeine is thought to increase the affinity of SR for calcium (Yamamoto and Kasai, 1982; Kirino et al., 1983) and to induce calcium release at physiological levels of free calcium in the cytoplasm even in the absence of calcium influx (Saida, 1982). However, the release of calcium from intracellular stores by transmembrane calcium influx has not yet been demonstrated in vascular smooth muscle. Calcium-induced contraction in depolarized muscles has long been believed to be caused directly by transmembrane calcium influx. The present data indicate that this contraction is dependent on stored calcium rather than on calcium entry, especially when the external calcium is low. Since ryanodine does not inhibit calcium influx, inhibition of this contraction by ryanodine suggests that transmembrane calcium influx can trigger calcium release from intracellular stores in vascular smooth muscle as it does in cardiac muscles (Fabiato, 1983). The present findings suggest that ryanodine is a useful tool to assess a contribution of calcium release from intracellular stores to mechanical activity of vascular smooth muscle. Our results suggest that ryanodine inhibits SR calcium release in guinea pig aortic smooth muscle. Ryanodine can both increase Circulation Research/Vol. 58, No. 5, May 1986 734 and decrese the calcium permeability of cardiac and skeletal SR membranes, depending on the ryanodine concentration and experimental conditions used (Lattanzio and Sutko, unpublished observations; G. Meissner, personal communication). Consequently, the actual effects of ryanodine will have to be established for different experimental protocols and types of smooth muscles. ILS is an Established Investigator of the American Heart Association. Address for reprints: Dr. Katsuaki Ho, Department of Veterinary Pharmacology, Faculty of Agriculture, University of Miyazaki, Miyazaki 889-21, ]apan. Received November 11, 1985; accepted for publication February 14, 1986. References Downloaded from http://circres.ahajournals.org/ by guest on June 18, 2017 Bond M, Kitazawa T, Somlyo AP, Somlyo AV (1984a) Release and recycling of calcium by the sarcoplasmic reticulum in guinea-pig portal vein smooth muscle. ] Physiol (Lond) 355: 677-695 Bond M, Shuman H, Somlyo AP, Somlyo AV (1984b) Total cytoplasmic calcium in relaxed and maximally contracted rabbit portal vein smooth muscle. J Physiol (Lond) 357: 185-201 Casteels R, Droogmans G (1981) Exchange characteristics of the noradrenaline-sensitive calcium store in vascular smooth muscle cells of rabbit ear artery. J Physiol (Lond) 317: 263-279 Deth R, Casteels R (1977) A study of releasable Ca fractions in smooth muscle cells of the rabbit aorta. ] Gen Physiol 69: 401416 Endo M (1977) Calcium release from the sarcomplasmic reticulum. Physiol Rev 57: 71-108 Fabiato A (1983) Calcium-induced release of calcium from the cardiac sarcomplasmic reticulum. Am J Physiol 245: C1-C14 Fabiato A (1985) Effects of ryanodine in skinned cardiac cells. Fed Proc 44: 2970-2976 Godfraind T (1976) Calcium exchange in vascular smooth muscle, action of noradrenaline and lanthanum. J Physiol (Lond) 260: 21-35 Itoh T, Kuriyama H, Suzuki H (1981) Excitation-contraction coupling in smooth muscle cells of the guinea-pig mesenteric artery. J Physiol (Lond) 321: 513-535 Itoh T, Kajiwara M, Kitamura K, Kuriyama H (1982) Roles of stored calcium on the mechanical response evoked in smooth muscle cells of the porcine coronary artery. J Physiol (Lond) 322: 107-125 Jacobs A, Keatinge WR (1974) Effects of procaine and lignocaine on electrical and mechanical activity of smooth muscle of sheep carotid arteries. Br ] Pharmacol 51: 405-411 Jenden DJ, Fairhurst AS (1969) The pharmacology of ryanodine. Pharmacol Rev 21: 1-25 Johansson B, Somlyo AP (1980) Electrophysiology and excitationcontraction coupling. In Handbook of Physiology, The Cardiovascular System, vol II, Vascular Smooth Muscle, edited by DF Bohr, AP Somlyo, HV Sparks. Washington, D.C., American Physiological Society, pp 301-323 Karaki H, Weiss GB (1979) Alterations in high and low affinity binding of 45Ca in rabbit aortic smooth muscle by norepinephrine and potassium after exposure to lanthanum and low temperature. J Pharmacol Exp Ther 211: 86-92 Karaki H, Weiss GB (1980a) Effects of stimulatory agents on mobilization of high and low affinity site 45Ca in rabbit aortic smooth muscle. J Pharmacol Exp Ther 213: 450-455 Karaki H, Weiss GB (1980b) Dissociation of varied actions of norepinephrine on 45Ca uptake and release at different sites in rabbit aortic smooth muscle. J Pharmacol Exp Ther 215: 363368 Kirino Y, Osakabe M, Shimizu H (1983) Ca2+-induced Ca2+ release from fragmented sacroplasmic reticulum: Ca2+-dependent passive Ca2+ efflux. J Biochem 94: 1111 -1118 Leijten PAA, Van Breemen C (1984) The effects of caffeine on the noradrenaline-sensitive calcium store in rabbit aorta. J Physiol (Lond) 357: 327-339 Saida K (1982) Intracellular Ca release in skinned smooth muscle. JGen Physiol 80: 191-202 Saida K, Van Breemen C (1984) Cyclic AMP modulation of adrenoceptor-mediated arterial smooth muscle contraction. J Gen Physiol 84: 307-318 Spedding M, Berg C (1985) Antagonism of Ca2+-induced contractions of K+-depolarized smooth muscle by local anaesthetics. Eur J Pharmacol 108: 143-150 Steinsland OS, Furchgott RF, Kirpekar SM (1973) Biphasic vasoconstriction of the rabbit ear artery. Circ Res 32: 49-58 Sutko JL, Willerson JT (1980) Ryanodine alterations of the contractile state of rat ventricular myocardium. Comparison with dog, cat, and rabbit ventricular tissues. Circ Res 46: 332-343 Sutko JL, Willerson JT, Templeton GH, Jones LR, Besch HR Jr (1979) Ryanodine: Its alterations of cat papillary muscle contractile state and responsiveness to inotropic interventions and a suggested mechanism of action. J Pharmacol Exp Ther 209: 37-47 Sutko JL, Ito K, Kenyon JL (1985) Ryanodine: A modifier of sarcoplasmic reticulum calcium release in striated muscle. Fed Proc 44: 2984-2988 Wheeler ES, Weiss GB (1979) Correlation between responses to norepinephrine and removal of 45Ca from high-affinity binding sites by extracellular EDTA in rabbit aortic smooth muscle. J Pharmacol Exp Ther 211: 353-359 Yamamoto N, Kasai M (1982) Kinetics of the actions of caffeine and procaine on the Ca2+ gated cation channel in sarcoplasmic reticulum vesicles. J Biochem 92: 477-484 INDEX TERMS: Ryanodine • Vascular smooth muscle. Calcium release • Contraction • Calcium fluxes Ryanodine inhibits the release of calcium from intracellular stores in guinea pig aortic smooth muscle. K Ito, S Takakura, K Sato and J L Sutko Downloaded from http://circres.ahajournals.org/ by guest on June 18, 2017 Circ Res. 1986;58:730-734 doi: 10.1161/01.RES.58.5.730 Circulation Research is published by the American Heart Association, 7272 Greenville Avenue, Dallas, TX 75231 Copyright © 1986 American Heart Association, Inc. All rights reserved. Print ISSN: 0009-7330. Online ISSN: 1524-4571 The online version of this article, along with updated information and services, is located on the World Wide Web at: http://circres.ahajournals.org/content/58/5/730 Permissions: Requests for permissions to reproduce figures, tables, or portions of articles originally published in Circulation Research can be obtained via RightsLink, a service of the Copyright Clearance Center, not the Editorial Office. Once the online version of the published article for which permission is being requested is located, click Request Permissions in the middle column of the Web page under Services. Further information about this process is available in the Permissions and Rights Question and Answer document. Reprints: Information about reprints can be found online at: http://www.lww.com/reprints Subscriptions: Information about subscribing to Circulation Research is online at: http://circres.ahajournals.org//subscriptions/